Galactosyltransferases in glycosaminoglycan synthesis (B4GALT7/B3GALT6)

Galactosyltransferases in glycosaminoglycan (GAG) synthesis, specifically Beta-1,4-galactosyltransferase 7 (B4GALT7) and Beta-1,3-galactosyltransferase 6 (B3GALT6), are essential enzymes for the assembly of the tetrasaccharide linkage region (GlcUA-Gal-Gal-Xyl) that attaches GAG chains to proteoglycan core proteins (UniProt Q9UBV7, Q96L58). B4GALT7 (GalT-I) transfers the first galactose to xylose, while B3GALT6 (GalT-II) transfers the second galactose (PMID: 23824651). These enzymes are critical for the production of chondroitin sulfate, dermatan sulfate, and heparan sulfate, which are vital components of the extracellular matrix. Mutations in the genes encoding these enzymes lead to severe connective tissue disorders, such as spondylodysplastic Ehlers-Danlos syndrome, characterized by skeletal abnormalities, skin hyperextensibility, and joint hypermobility (PMID: 28306229). While not currently the primary targets of approved systemic drugs, they are significant in research for substrate reduction therapies and as potential targets in oncology, where altered GAG synthesis influences tumor progression and metastasis. Experimental compounds such as xyloside analogs can compete with these enzymes or act as artificial primers to bypass their function in research settings (PMID: 15131074).

Other names

Beta-1,4-galactosyltransferase 7Beta-1,3-galactosyltransferase 6Galactosyltransferase IGalactosyltransferase IIB4GALT7B3GALT6GalT-IGalT-II

Substrate competition or enzymatic inhibition of glycosyltransferase activity